Anna is a Research Assistant within the School of Medical Sciences.
BSc (Bachelor of Science), Murdoch University, 2008 .
Recent Research Grants
Predictive significance of circulating tumour cells (CTCs), circulating tumour DNA (ctDNA) and serum vascular endothelial growth factor (VEGF) in advanced melanoma patients treated with pembrolizumab,
Merck Sharp and Dohme (Australia) Pty Ltd,
2015 - 2016, $73,300.
Neon Transfection System and Biomedical Research Grade -30oC Freezer for Alzheimer?s and Melanoma Research,
National Health and Medical Research Council,
Equipment Grant 2011,
Recent Publications (within the last five years)
Klinac, D., Gray, E., Freeman, J., Reid, A., Bowyer, S., Millward, M., Ziman, M., (2014), Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma. BMC Cancer, 14(1), Article number 423, United Kingdom, DOI: 10.1186/1471-2407-14-423.
Reid, A., Millward, M., Pearce, R., Lee, M., Frank, M., Ireland, A., Monshizadeh, L., Rai, T., Heenan, P., Medic, S., Kumarasinghe, P., Ziman, M., (2013), Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. British Journal of Dermatology, 168(1), 85-92, DOI: 10.1111/bjd.12057.